Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Bolt Biotherapeutics Inc.
Sponsor

Bolt Biotherapeutics Inc.

United States 900 Chesapeake Drive, 94063-4727, United States

About the sponsor

Clinical research in human epidermal growth factor receptor 2-positive metastatic breast cancer, with interest in patients who have received prior HER2-directed treatment.

  • HER2-positive metastatic breast cancer
  • Previously treated disease
  • Anti-tumor activity

The sponsor’s studies in this area focus on treatment options for advanced breast malignancies driven by HER2 expression.

About Specializations

Bolt Biotherapeutics Inc. runs clinical trials in conditions such as HER2 protein overexpression, Malignant mast cell neoplasm, Breast cancer metastatic, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

HER2 protein overexpression+1

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bdc-1001
  • Sponsor:Bolt Biotherapeutics Inc.

Breast cancer metastatic

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bdc-1001
  • Sponsor:Bolt Biotherapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.